Published in Clin Genet on July 31, 2011
Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet (2011) 1.94
Notch signaling in human development and disease. Semin Cell Dev Biol (2012) 1.79
NOTCH signaling in skeletal progenitors is critical for fracture repair. J Clin Invest (2016) 1.41
Genetic, environmental, and epigenetic factors involved in CAKUT. Nat Rev Nephrol (2015) 1.00
New Genetic Insights into Congenital Heart Disease. J Clin Exp Cardiolog (2012) 0.89
RBP-Jκ-dependent Notch signaling is required for murine articular cartilage and joint maintenance. Arthritis Rheum (2013) 0.85
Alagille syndrome and a JAG1 mutation: 41 cases of experience at a single center. Korean J Pediatr (2015) 0.82
JAG1 Mutation Spectrum and Origin in Chinese Children with Clinical Features of Alagille Syndrome. PLoS One (2015) 0.80
Alagille syndrome: clinical perspectives. Appl Clin Genet (2016) 0.79
Spectrum of JAG1 gene mutations in Polish patients with Alagille syndrome. J Appl Genet (2014) 0.79
Clinical utility gene card for: Alagille Syndrome (ALGS). Eur J Hum Genet (2013) 0.78
Alagille Syndrome Mimicking Biliary Atresia in Early Infancy. PLoS One (2015) 0.76
Hypertension and Biliary Ductopenia in a Patient with Duplication of Exon 6 of the JAG1 Gene. Clin Med Insights Pediatr (2012) 0.75
Polymorphism analysis and new JAG1 gene mutations of Alagille syndrome in Mexican population. Meta Gene (2013) 0.75
JAGGED1 gene variations in Chinese twin sisters with Alagille syndrome. Int J Clin Exp Pathol (2015) 0.75
Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia (2010) 4.13
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet (1998) 2.53
Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos Trans R Soc Lond B Biol Sci (2003) 2.34
Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet (2000) 2.28
Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet (2005) 2.24
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia (2006) 2.24
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet (2000) 2.09
A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet (2001) 1.98
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia (2012) 1.89
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology (2007) 1.89
Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int (2000) 1.87
Bladder injection of "naked" hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. Am J Physiol Regul Integr Comp Physiol (2001) 1.83
Seeking quality. Lancet (1983) 1.74
Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia (2009) 1.70
Rapid concentration of bacteriophages from aquatic habitats. J Appl Bacteriol (1977) 1.66
Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet (2000) 1.64
Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest (1999) 1.60
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia (2005) 1.60
The laminopathies: a clinical review. Clin Genet (2006) 1.59
Delineation of two distinct 6p deletion syndromes. Hum Genet (1999) 1.59
A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med (2009) 1.54
SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia (2012) 1.54
Cardiac and arterial interactions in end-stage renal disease. Kidney Int (1996) 1.53
Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology (1998) 1.51
Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies. Mol Pathol (2000) 1.48
Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients. Diabetologia (2013) 1.48
beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes (2001) 1.47
Autosomal dominant polycystic kidney disease with primary hyperaldosteronism. Nephrol Dial Transplant (1992) 1.46
Hyperinsulinaemic hypoglycaemia. Arch Dis Child (2009) 1.44
The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series. Diabet Med (2014) 1.42
Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol (2010) 1.39
Hepatocyte nuclear factor-1beta: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol (2001) 1.36
Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. Am J Hum Genet (2005) 1.31
Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes (1997) 1.29
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet (2001) 1.26
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes (2001) 1.25
Expression of normal and mutant huntingtin in the developing brain. J Neurosci (1996) 1.21
Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med (2010) 1.20
Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabet Med (2009) 1.20
Novel mutations in DLL3, a somitogenesis gene encoding a ligand for the Notch signalling pathway, cause a consistent pattern of abnormal vertebral segmentation in spondylocostal dysostosis. J Med Genet (2003) 1.19
Genetic analysis of amidase mutants of Pseudomonas aeruginosa. Genet Res (1974) 1.19
Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development. Diabet Med (2006) 1.18
The mutated human gene encoding hepatocyte nuclear factor 1beta inhibits kidney formation in developing Xenopus embryos. Proc Natl Acad Sci U S A (2000) 1.16
Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med (2001) 1.13
Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation. Ann Oncol (2007) 1.12
Confirmation of linkage of Duane's syndrome and refinement of the disease locus to an 8.8-cM interval on chromosome 2q31. Hum Genet (2000) 1.11
Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia (2011) 1.09
Drug-resistant enteric fever in the UK. Lancet (2006) 1.08
Novel GLIS3 mutations demonstrate an extended multisystem phenotype. Eur J Endocrinol (2010) 1.08
Four cases of amelia of the upper limb associated with anal atresia--is this VACTERL with extreme limb involvement? Clin Dysmorphol (1998) 1.07
Evaluation of 'Alcotest R80' reagent tubes. Nature (1968) 1.07
The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol (2011) 1.06
Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur J Neurosci (1999) 1.06
Mental health in older adult recipients of primary care services: is depression the key issue? Identification, treatment and the general practitioner. Int J Geriatr Psychiatry (2002) 1.06
Formic acid decalcification of bone marrow trephines degrades DNA: alternative use of EDTA allows the amplification and sequencing of relatively long PCR products. Mol Pathol (2000) 1.04
Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype. Diabetologia (2012) 1.04
C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet (1998) 1.03
HNF1B deletions in patients with young-onset diabetes but no known renal disease. Diabet Med (2013) 1.02
The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria. Diabetes (2001) 1.01
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199). Gynecol Oncol (2013) 0.99
Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia. Diabetologia (2008) 0.99
Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period. Diabetes Obes Metab (2007) 0.98
A potentially useful distribution model for dietary intake data. Public Health Nutr (2003) 0.98
Mutations in hepatocyte nuclear factor 1beta are not a common cause of maturity-onset diabetes of the young in the U.K. Diabetes (1998) 0.98
Pancreatic hypoplasia presenting with neonatal diabetes mellitus in association with congenital heart defect and developmental delay. Am J Med Genet A (2010) 0.98
A gene for autosomal recessive spondylocostal dysostosis maps to 19q13.1-q13.3. Am J Hum Genet (1999) 0.98
Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy. Diabet Med (2007) 0.97
Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failure. Eur J Clin Pharmacol (1988) 0.97
Ascertainment of myotonic dystrophy through cataract by selective screening. J Med Genet (1995) 0.97
Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia. Clin Genet (2011) 0.97
Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging (2001) 0.96
Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000. J Clin Oncol (2003) 0.96
Abnormal splicing of hepatocyte nuclear factor-1 beta in the renal cysts and diabetes syndrome. Diabetologia (2004) 0.96
Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics. Diabet Med (2002) 0.96
Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol (1983) 0.95
Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med (2010) 0.95
Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X-linked deafness, DFN3. Hum Mol Genet (1995) 0.95
Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome. J Inherit Metab Dis (2008) 0.94
Permanent neonatal diabetes in an Asian infant. J Pediatr (2005) 0.93
Management of kidney cancer: canadian kidney cancer forum consensus update 2011. Can Urol Assoc J (2012) 0.92
Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice. Neuroscience (2011) 0.92
Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY). Hum Mutat (2003) 0.92
Asian MODY: are we missing an important diagnosis? Diabet Med (2006) 0.91
The uptake of amines by human erythrocytes in vitro. J Physiol (1967) 0.91
Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia (2011) 0.90
No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians. J Clin Endocrinol Metab (2000) 0.90
Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young. Diabetologia (2002) 0.89
Maturity onset diabetes of the young (MODY) and early onset Type II diabetes are not caused by loss of imprinting at the transient neonatal diabetes (TNDM) locus. Diabetologia (2001) 0.89
Feasibility study of N-of-1 trials with blood pressure self-monitoring in hypertension. Hypertension (1995) 0.89
Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio. J Hypertens Suppl (1994) 0.88
Further results from a census based mortality study of fertiliser manufacturers. Br J Ind Med (1989) 0.88
ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease. Diabetes Care (2001) 0.88
A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications. Diabetologia (2008) 0.87
Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene. J Clin Endocrinol Metab (2008) 0.87